Elpis closes funding round

Elpis has closed a funding round backed by top life sciences investors. The funds will be used to grow the company‚Äôs catalogue of human cell type products and expand its service offerings. This marks our first step towards more complex products, including human organ-on-chip models, and cell-based therapies. Jonathan Milner Read more…

Elpis receives Innovate UK grant

Elpis has received a grant from Innovate UK to investigate the use of its technology for cell therapy. The project will look at the feasibility of using Elpis oligodendrocytes (a nervous system support cell) as therapy for spinal cord injury. This is a promising application of the technology for cell Read more…